IRIS
NARDONE, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.560
AS - Asia 2.737
NA - Nord America 1.734
SA - Sud America 483
AF - Africa 27
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.547
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.067
US - Stati Uniti d'America 1.676
SG - Singapore 1.035
IE - Irlanda 713
CN - Cina 553
HK - Hong Kong 540
BR - Brasile 416
IT - Italia 364
KR - Corea 191
VN - Vietnam 170
DE - Germania 158
IN - India 75
GB - Regno Unito 63
JP - Giappone 53
AT - Austria 31
AR - Argentina 25
FI - Finlandia 23
NL - Olanda 23
BD - Bangladesh 22
CA - Canada 21
FR - Francia 21
MX - Messico 20
GR - Grecia 18
BE - Belgio 16
IQ - Iraq 14
PK - Pakistan 14
EC - Ecuador 13
CZ - Repubblica Ceca 11
PL - Polonia 11
TR - Turchia 10
UA - Ucraina 10
UZ - Uzbekistan 9
ID - Indonesia 8
SE - Svezia 8
ZA - Sudafrica 8
CO - Colombia 7
IR - Iran 7
MA - Marocco 6
SA - Arabia Saudita 6
VE - Venezuela 6
CR - Costa Rica 5
PE - Perù 5
CL - Cile 4
EG - Egitto 4
ES - Italia 4
LT - Lituania 4
UY - Uruguay 4
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
OM - Oman 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
HN - Honduras 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
KE - Kenya 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NR - Nauru 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 8.547
Salva come PNG Salva come JPEG
Città #
Dublin 713
Moscow 677
Hong Kong 537
Santa Clara 535
Singapore 401
Seoul 191
Chandler 168
Hefei 153
Naples 87
Dallas 83
Roxbury 74
Princeton 73
Ashburn 72
The Dalles 69
Beijing 68
Bremen 61
Bengaluru 60
Cambridge 57
Ho Chi Minh City 53
Munich 38
São Paulo 38
Hanoi 37
New York 33
Jacksonville 30
Dong Ket 26
Nuremberg 19
Rio de Janeiro 18
Los Angeles 17
Brussels 16
Medford 16
Boardman 15
Falkenstein 14
Des Moines 13
Aversa 12
Frankfurt am Main 12
Belo Horizonte 11
Vienna 11
Helsinki 10
Brno 9
Newark 9
Tashkent 9
Amsterdam 8
Campinas 8
Goiânia 8
Lappeenranta 8
Milan 8
Ann Arbor 7
Warsaw 7
Atlanta 6
Curitiba 6
Haiphong 6
Phoenix 6
Rome 6
Solofra 6
Tianjin 6
Tokyo 6
Brooklyn 5
Chennai 5
Da Nang 5
Dhaka 5
Guayaquil 5
Lima 5
Montreal 5
Salerno 5
San Francisco 5
San José 5
Stockholm 5
Viamão 5
Baghdad 4
Bari 4
Brasília 4
Criciúma 4
Hangzhou 4
Ipatinga 4
Jakarta 4
Jinan 4
Johannesburg 4
Lahore 4
London 4
Manchester 4
Mexico City 4
Nova Iguaçu 4
Piscataway 4
Porto Alegre 4
Praia Grande 4
Pune 4
Quito 4
Shenzhen 4
Strasbourg 4
Taboão da Serra 4
Toronto 4
Trento 4
Turku 4
Amman 3
Belém 3
Bogotá 3
Cairo 3
Camaçari 3
Caraguatatuba 3
Cardito 3
Totale 4.828
Salva come PNG Salva come JPEG
Nome #
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 128
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 113
Delta radiomics: a systematic review 105
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy 103
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery 101
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 101
4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy 101
MRI Radiomics in Prostate Cancer: A Reliability Study 99
CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial 98
Radiomics as a new frontier of imaging for cancer prognosis: A narrative review 96
Secondary Complications in COVID-19 Patients: A Case Series 94
Delta-radiomics increases multicentre reproducibility: a phantom study 93
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 93
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 92
"RT STRIKES BACK": Radiotherapy in Ultra Elderly with Cutaneous Basal Cell Carcinoma 90
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 90
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 90
Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review 88
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 86
Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy 85
Abemaciclib for malignant pleural mesothelioma 84
Non-Oncological Radiotherapy: A Review of Modern Approaches 84
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 83
Choosing the optimal gated window for defining target volume in lung stereotactic ablative radiotherapy 83
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 82
Artificial intelligence applied to image-guided radiation therapy (IGRT): a systematic review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 82
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 80
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 80
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk 80
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology 79
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment 79
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 77
Quantitative Evaluation of the Lymph Node Metastases in the Head and Neck Malignancies Using Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping: A Bicentric Study 76
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 76
Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation 75
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 75
Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients 75
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool 75
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 74
Robustness of Radiomics in Pre-Surgical Computer Tomography of Non-Small-Cell Lung Cancer 74
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 73
Feasibility of stereotactic ablative reirradiation in breast cancer patient undergoing palbociclib: A case report 73
Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis 72
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer 71
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures 70
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: A role for autophagy 70
A critical review on oligometastatic disease: a radiation oncologist’s perspective 69
Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in Italy 69
Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI 68
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 68
Identification of perineural invasion at imaging staging as a novel potential risk factor in rectal cancer: A case report 67
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 67
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 66
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 66
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus 65
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 65
Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative review 64
Effects of CT FOV displacement and acquisition parameters variation on texture analysis features 64
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 64
Are you planning to be a radiation oncologist? A survey by the young group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 63
Genetic profiling in radiotherapy: a comprehensive review 62
Pitfalls and differential diagnosis on adrenal lesions: current concepts in CT/MR imaging: a narrative review 62
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 62
Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point? 62
Could PD-1/PDL1 immune checkpoints be linked to HLA signature? 61
Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis 60
Prognostic Value of Sarcopenia in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer Undergoing Radiotherapy 60
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 58
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy 58
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 58
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 58
Feasibility of ultra-central stereotactic ablative irradiation in lung cancer undergoing nivolumab: A case report 58
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients 58
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients 57
Delayed enhancement in differential diagnosis of salivary gland neoplasm 57
The role of coronary artery calcification score in lung cancer patients 57
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 57
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy 57
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma 56
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 56
The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer 56
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 56
Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak 56
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 55
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 55
Texture Analysis in Cancer Prognosis 54
The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique 53
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 53
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement 52
Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel 52
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (Front. Oncol., (2021), 11, (744956), 10.3389/fonc.2021.744956) 52
Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses? 52
Neck emphysema in a HNSCC cancer patient undergoing concurrent radiotherapy and cetuximab 52
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 52
The role of radiation therapy and systemic therapies in elderly with breast cancer 52
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 52
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 51
The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 50
Chemoradiotherapy for Head and Neck Cancer 50
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 49
Totale 7.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 6 14 1 1 1 21 28
2021/2022405 3 1 0 1 46 6 50 21 11 76 30 160
2022/20231.041 83 11 31 52 108 52 19 51 575 8 32 19
2023/2024570 39 29 26 36 202 32 18 16 15 6 46 105
2024/20252.424 12 52 34 74 376 352 322 222 332 343 153 152
2025/20264.185 339 504 466 395 742 1.739 0 0 0 0 0 0
Totale 8.800